Oral glucose tolerance test should be performed after stroke and transient ischemic attack

International Journal of Stroke

Volumn 6, Issue 4, 2011, Pages 317-320

  Lindsberg, Perttu J ^a   Tuomi, Tiinamaija ^a   Kaste, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Epidemiology; Ischemic stroke; Lipids; Prevention; Risk factors; Socio economic factors; Statins

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; SCREENING; STROKE; TRANSIENT ISCHEMIC ATTACK;

DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; ISCHEMIC ATTACK, TRANSIENT; STROKE;

EID: 79960240127     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00619.x     Document Type: Article

References (25)

1. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006; 368:1651-9.
2. Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus. Diagnostic and prognostic value. Circulation 2006; 113:583-92.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426-32.
4. Charles MA, Balkau B, Vauzelle-Kervroedan F, Thibult N, Eschwege E. Revision of diagnostic criteria for diabetes. Lancet 1996; 348:1657-8.
5. Goldstein LB, Bushnell CD, Adams RJ et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011; 42:517-584.
6. Hillen T, Coshall C, South London Stroke Register et al. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003; 34:1457-63.
7. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 2004; 35:363-4.
8. Kernan WN, Viscoli CM, Inzucchi SE et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 2005; 165:227-33.
9. Vancheri F, Curcio M, Burgio A et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM 2005; 98:871-8.
10. Matz K, Keresztes K, Tatschl C et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care 2006; 29:792-7.
11. World Health Organization and International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO Document Production Services, 2006: 13-27.
12. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. Stroke 2011; 42:227-76.
13. Ringleb PA, Bousser MG, Ford G et al. for the European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25:457-507.
14. Klijn CJ, Hankey GJ., American Stroke Association and European Stroke Initiative. Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003; 2:698-701.
15. Sacco RL, Adams R, Albers G, et al. for the American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37:577-617.
16. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care 2003; 26:61-9.
17. Qiao Q, Hu G, DECODA Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian Cohorts. Diabetes Care 2003; 26:1770-80.
18. DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317:371-5.
19. Bartnik M, Rydén L, Euro Heart Survey Investigators. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007; 93:72-7.
20. Wallander M, Malmberg K, Norhammar A, Rydén L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008; 31:36-8.
21. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 1998; 352:854-65.
22. Tuomilehto J, Lindström J, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50.
23. The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
24. Lindström J, Ilanne-Parikka P, Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368:1673-9.
25. Gillies CL, Abrams KR, Lambert PC et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334:299-302.